Group One Trading’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.1K Buy
2,019
+1,919
+1,919% +$56.8K ﹤0.01% 5196
2026
Q1
$3.02K Hold
100
﹤0.01% 6921
2025
Q4
$3.47K Sell
100
-400
-80% -$14.1K ﹤0.01% 7340
2025
Q3
$18.2K Sell
500
-238
-32% -$8.09K ﹤0.01% 6775
2025
Q2
$23.2K Buy
+738
New +$22.9K ﹤0.01% 6166
2024
Q4
Sell
-18,288
Closed -$578K 7588
2024
Q3
$569K Buy
+18,288
New +$665K ﹤0.01% 2759
2022
Q4
Sell
-100
Closed -$5.63K 7629
2022
Q3
$5K Buy
+100
New +$4.77K ﹤0.01% 6828

Other funds holding IMCR

Group One Trading's IMCR Position: Q2 2026 in Review

Group One Trading increased its Immunocore (IMCR) stake by 1,919% in Q2 2026, buying an estimated $56.8K and bringing the position to 2,019 shares worth $64.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5196.

Group One Trading first reported a position in IMCR in Q3 2022 and has held it in 7 quarters since. The position peaked at $569K in Q3 2024. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Group One Trading held 2,019 shares of Immunocore worth $64.1K as of Q2 2026.
  • Group One Trading bought 1,919 Immunocore shares in Q2 2026, an estimated $56.8K.
  • Immunocore made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5196 holding.
  • Group One Trading first reported a position in Immunocore in Q3 2022 and has held it in 7 quarters since.
  • Group One Trading's Immunocore position peaked at $569K in Q3 2024.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.